O'Connell M A, Gerber A P, Zukin R S
Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA.
Neuroscience. 2000;95(3):869-79. doi: 10.1016/s0306-4522(99)00431-5.
To date, two structurally related RNA-editing enzymes with adenosine deaminase activity have been identified in mammalian tissue: ADAR1 and ADAR2 [Bass B. I. et al. (1997) RNA 3, 947-949]. In rodents, ADAR2 undergoes alternative RNA splicing, giving rise to two splice variants that differ by the presence or absence of a 10-amino-acid insert in the carboxy-terminal catalytic domain. However, the physiological significance of the splicing and its regional and developmental regulation are as yet unknown. The present study examined spatial and temporal patterns of ADAR2 gene transcripts within specific neuronal populations of rat brain. The two rodent ADAR2 isoforms were expressed at comparable levels at all ages examined. rADAR2 messenger RNA expression was first detectable in the thalamic nuclei formation at embryonic day E19. The rADAR2b insert and rADAR2a splice probes produced images similar to that of the rADAR2 pan probe. At birth, rADAR2a messenger RNA splice variants were abundantly expressed in the thalamic nuclei. No signal for any probe was detectable in other brain regions, including neocortex, hippocampus, striatum and cerebellum at this stage of development. During the first week of postnatal life, rADAR2 messenger RNA expression (detected with the pan probe) increased gradually in several brain regions, with low expression detected at postnatal day P7 in the olfactory bulb, inferior colliculus, and within the pyramidal and granule cell layers of the hippocampus. Hybridization patterns of the rADAR2a variant probe reached peak expression at about the second week of life, while peak expression of the rADAR2b probe was reached at about the third week of life. At the end of the first week of life (P7), expression of both splice variants was strongest in the thalamic nuclei. By P14, rADAR2 messenger RNA expression was more consolidated in the deeper structures, including the thalamic nuclei and the granule cell layer of the cerebellum. By P21, maximal levels of rADARb expression were observed in the thalamic nuclei, inferior colliculus, cerebellum and pontine nuclei. In the adult, rADAR2 messenger RNA expression was of highest intensity in the thalamic nuclei, with high levels of expression in the olfactory bulb, inferior colliculus, cerebellum and pontine nuclei. At the level of the hippocampus, positive labelling was restricted to the CA3 region of the Ammon's horn and the dentate gyrus, with weak signals in the CA1 subfield. rADAR2 pan expression was at near background levels throughout the neocortex and caudate putamen. In summary, our study shows that ADAR2 messenger RNA expression is regulated in a cell-specific manner throughout development. At early ages, ADAR2 messenger RNA is expressed only within (and restricted to) the thalamic nuclei. By the third postnatal week, expression of the editase enzyme is more widely distributed throughout the olfactory bulb, CA3 and dentate gyrus of the hippocampus, thalamus, inferior colliculus and the molecular cell layer of the cerebellum. ADAR2 is thought to act at specific nucleotide positions in primary transcripts encoding glutamate receptor subunits, thereby altering gating and ionic permeability properties of AMPA- and kainate-activated channels. ADAR2 also acts at pre-messenger RNA encoding the serotonin 5HT-2C receptor to alter G-protein coupling. Thus, RNA editing may be an important mechanism for fine-tuning of the physiological and pharmacological properties of transmitter receptors of the central nervous system.
迄今为止,在哺乳动物组织中已鉴定出两种具有腺苷脱氨酶活性且结构相关的RNA编辑酶:ADAR1和ADAR2 [巴斯·B.I.等人(1997年),《RNA》3,947 - 949]。在啮齿动物中,ADAR2经历可变RNA剪接,产生两种剪接变体,它们在羧基末端催化结构域中存在或不存在一个10个氨基酸的插入片段而有所不同。然而,这种剪接的生理意义及其区域和发育调控尚不清楚。本研究检测了大鼠脑特定神经元群体中ADAR2基因转录本的时空模式。在所有检测的年龄段,两种啮齿动物ADAR2同工型的表达水平相当。rADAR2信使核糖核酸表达在胚胎第19天首次在丘脑核形成中被检测到。rADAR2b插入片段和rADAR2a剪接探针产生的图像与rADAR2泛探针的图像相似。出生时,rADAR2a信使核糖核酸剪接变体在丘脑核中大量表达。在发育的这个阶段,在包括新皮层、海马体、纹状体和小脑在内的其他脑区,任何探针均未检测到信号。在出生后的第一周,rADAR2信使核糖核酸表达(用泛探针检测)在几个脑区逐渐增加,在出生后第7天,在嗅球、下丘以及海马体的锥体细胞层和颗粒细胞层中检测到低水平表达。rADAR2a变体探针的杂交模式在出生后约第二周达到表达峰值,而rADAR2b探针的峰值表达在出生后约第三周达到。在出生后第一周结束时(P7),两种剪接变体在丘脑核中的表达最强。到P14时,rADAR2信使核糖核酸表达在更深的结构中更稳定,包括丘脑核和小脑的颗粒细胞层。到P21时,在丘脑核、下丘、小脑和脑桥核中观察到rADARb表达的最高水平。在成体中,rADAR2信使核糖核酸表达在丘脑核中强度最高,在嗅球、下丘、小脑和脑桥核中表达水平较高。在海马体水平,阳性标记仅限于海马角的CA3区和齿状回,在CA1亚区信号较弱。rADAR2泛表达在整个新皮层和尾状壳核中接近背景水平。总之,我们的研究表明,ADAR2信使核糖核酸表达在整个发育过程中以细胞特异性方式受到调控。在早期,ADAR2信使核糖核酸仅在(且局限于)丘脑核中表达。到出生后第三周,编辑酶的表达更广泛地分布在嗅球、海马体的CA3区和齿状回、丘脑、下丘以及小脑的分子细胞层中。ADAR2被认为作用于编码谷氨酸受体亚基的初级转录本中的特定核苷酸位置,从而改变AMPA和海人藻酸激活通道的门控和离子通透性特性。ADAR2还作用于编码5-羟色胺5HT-2C受体的前信使核糖核酸以改变G蛋白偶联。因此,RNA编辑可能是微调中枢神经系统递质受体的生理和药理特性的重要机制。